本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Ginkgo Bioworks Holdings Inc.

7.01
+0.00010.00%
成交量:48.92萬
成交額:345.67萬
市值:4.72億
市盈率:-1.41
高:7.18
開:6.94
低:6.92
收:7.01
52周最高:17.58
52周最低:5.37
股本:6,734.03萬
流通股本:4,987.32萬
量比:0.59
換手率:0.98%
股息:- -
股息率:- -
每股收益(TTM):-4.9625
每股收益(LYR):-5.6397
淨資產收益率:-59.94%
總資產收益率:-16.72%
市淨率:1.12
市盈率(LYR):-1.24

資料載入中...

2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/01/27

重要事件披露

8-K - Current report
2023/01/25

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/01/25

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/01/11

重要事件披露

8-K - Current report
2022/11/18

重要事件披露

8-K - Current report
2022/11/14

重要事件披露

8-K - Current report
2022/11/14

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/10/19

重要事件披露

8-K - Current report
2022/10/19

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/10/12

SEC問詢函

CORRESP [Cover] - Correspondence
2022/10/11

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/10/05

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/10/05

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/10/04

重要事件披露

8-K - Current report